DK43382A - Alkanolaminderivater - Google Patents

Alkanolaminderivater

Info

Publication number
DK43382A
DK43382A DK43382A DK43382A DK43382A DK 43382 A DK43382 A DK 43382A DK 43382 A DK43382 A DK 43382A DK 43382 A DK43382 A DK 43382A DK 43382 A DK43382 A DK 43382A
Authority
DK
Denmark
Prior art keywords
carbon atoms
benzo
bears
unsubstituted
alkylene
Prior art date
Application number
DK43382A
Other languages
English (en)
Inventor
J J Barlow
L H Smith
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK43382A publication Critical patent/DK43382A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK43382A 1981-02-02 1982-02-01 Alkanolaminderivater DK43382A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8103131 1981-02-02

Publications (1)

Publication Number Publication Date
DK43382A true DK43382A (da) 1982-08-03

Family

ID=10519390

Family Applications (1)

Application Number Title Priority Date Filing Date
DK43382A DK43382A (da) 1981-02-02 1982-02-01 Alkanolaminderivater

Country Status (21)

Country Link
US (1) US4399138A (da)
EP (1) EP0057572B1 (da)
JP (1) JPS57163370A (da)
KR (1) KR830009069A (da)
AT (1) ATE14576T1 (da)
AU (1) AU550763B2 (da)
CA (1) CA1198110A (da)
DE (1) DE3264964D1 (da)
DK (1) DK43382A (da)
ES (1) ES8304952A1 (da)
FI (1) FI820266A7 (da)
GR (1) GR75872B (da)
HU (1) HU187634B (da)
IE (1) IE52345B1 (da)
IL (1) IL64890A (da)
NO (1) NO820291L (da)
NZ (1) NZ199627A (da)
PH (1) PH18070A (da)
PT (1) PT74373B (da)
YU (1) YU22082A (da)
ZA (1) ZA82562B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3361244D1 (de) * 1982-01-29 1986-01-02 Ici Plc Alkanolamine derivatives
US4604394A (en) * 1984-10-01 1986-08-05 Merck & Co., Inc. Antiarrhythmic compositions and method
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
US4803206A (en) * 1988-03-07 1989-02-07 Schering Corporation Antihypertensive acylpyrazines
GB8812343D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Amino compounds
GB8812342D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Bicyclic compounds
UY36034A (es) 2014-03-18 2015-09-30 Astrazeneca Ab Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472847A (en) * 1966-08-25 1969-10-14 Merck & Co Inc Conversion of pyrazinoylcyanamides to pyrazinoylguanidines
US3577418A (en) * 1969-02-12 1971-05-04 Merck & Co Inc Pyrazinamide derivatives and processes for their preparation
US3573306A (en) * 1969-03-05 1971-03-30 Merck & Co Inc Process for preparation of n-substituted 3,5-diamino-6-halopyrazinamides
US3544568A (en) * 1969-03-18 1970-12-01 Merck & Co Inc 3-amino-5,6-substituted pyrazinamides
US3655663A (en) * 1969-04-21 1972-04-11 Burton K Wasson 4-(3-secondary amino-2-hydroxy-proxy) 1 2 5-thiadiazoles
US3948895A (en) * 1971-09-28 1976-04-06 E. I. Du Pont De Nemours And Company Synthesis of 3,5-diaminopyrazinoic acid from 3,5-diamino-2,6-dicyanopyrazine and intermediates
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4139623A (en) * 1974-05-14 1979-02-13 C-G Corp. Cyclic-substituted derivatives of 1-amino-2-propanol
US4115409A (en) * 1975-12-05 1978-09-19 Imperial Chemical Industries Limited Alkanolamine derivatives
US4085211A (en) * 1975-12-15 1978-04-18 Merck & Co., Inc. Pyrazinecarboxamides and processes for preparing same
GB1540463A (en) * 1976-10-07 1979-02-14 Ici Ltd Alkanolamine derivatives
US4219561A (en) * 1977-09-22 1980-08-26 Imperial Chemical Industries Limited Alkanolamine derivatives

Also Published As

Publication number Publication date
HU187634B (en) 1986-02-28
NZ199627A (en) 1984-11-09
ATE14576T1 (de) 1985-08-15
ES509250A0 (es) 1983-03-16
PT74373A (en) 1982-03-01
EP0057572A1 (en) 1982-08-11
EP0057572B1 (en) 1985-07-31
IL64890A (en) 1986-09-30
FI820266L (fi) 1982-08-03
IE820175L (en) 1982-08-02
YU22082A (en) 1985-04-30
NO820291L (no) 1982-08-03
ZA82562B (en) 1982-12-29
US4399138A (en) 1983-08-16
JPS57163370A (en) 1982-10-07
KR830009069A (ko) 1983-12-17
AU550763B2 (en) 1986-04-10
CA1198110A (en) 1985-12-17
PH18070A (en) 1985-03-18
IE52345B1 (en) 1987-09-16
FI820266A7 (fi) 1982-08-03
PT74373B (en) 1983-07-14
DE3264964D1 (de) 1985-09-05
IL64890A0 (en) 1982-03-31
GR75872B (da) 1984-08-02
AU7994682A (en) 1982-08-12
ES8304952A1 (es) 1983-03-16

Similar Documents

Publication Publication Date Title
RU95108329A (ru) Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция
KR890005095A (ko) 신규 화합물들
AU550763B2 (en) Alkanolamine derivatives
ES8601934A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina.
SE8505715D0 (sv) Indolderivat
IL63190A0 (en) Imidazole derivatives,processes for their manufacture and pharmaceutical preparations containing them
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
DE3769451D1 (de) Indan-derivate, verfahren zu ihrer herstellung und die erhaltenen zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
KR910007901A (ko) 5-{2-[(2-아미노-2-옥소에틸)(메틸)아미노] 에틸}-2,3-디히드로-3-히드록시-2-(4-메톡시페닐)-1,5(5h)-벤조티아제핀-4-온 유도체. 그의 제조 및 치료에 있어서의 그의 이용
AU561149B2 (en) Cardiotonic 4-semicarbazide quindyolines
IE800115L (en) Pharmaceutical compositions, containing a benzo £c| £1,6|¹naphthyridine
ATE16807T1 (de) Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment